188 related articles for article (PubMed ID: 25382971)
61. DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies.
Seidl S; Ackermann J; Kaufmann H; Keck A; Nösslinger T; Zielinski CC; Drach J; Zöchbauer-Müller S
Cancer; 2004 Jun; 100(12):2598-606. PubMed ID: 15197802
[TBL] [Abstract][Full Text] [Related]
62. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A
Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195
[TBL] [Abstract][Full Text] [Related]
63. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
64. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA.
Yu W; Gius D; Onyango P; Muldoon-Jacobs K; Karp J; Feinberg AP; Cui H
Nature; 2008 Jan; 451(7175):202-6. PubMed ID: 18185590
[TBL] [Abstract][Full Text] [Related]
65. Methylation status of the p15, p16 and MGMT promoter genes in primary cutaneous T-cell lymphomas.
Gallardo F; Esteller M; Pujol RM; Costa C; Estrach T; Servitje O
Haematologica; 2004 Nov; 89(11):1401-3. PubMed ID: 15531468
[TBL] [Abstract][Full Text] [Related]
66. Modified CDKN2B (p15) and CDKN2A (p16) DNA methylation profiles in urban pesticide applicators.
Herrera-Moreno JF; Medina-Díaz IM; Bernal-Hernández YY; Ramos KS; Alvarado-Cruz I; Quintanilla-Vega B; González-Arias CA; Barrón-Vivanco BS; Rojas-García AE
Environ Sci Pollut Res Int; 2019 May; 26(15):15124-15135. PubMed ID: 30924039
[TBL] [Abstract][Full Text] [Related]
67. p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies.
Mateos MV; Garcia-Sanz R; López-Pérez R; Balanzategui A; González MI; Fernández-Calvo J; Moro MJ; Hernández J; Caballero MD; González M; San Miguel JF
Hematol J; 2001; 2(3):146-9. PubMed ID: 11920239
[TBL] [Abstract][Full Text] [Related]
68. Joint Effects Between CDKN2B/P15 Methylation and Environmental Factors on the Susceptibility to Gastric Cancer.
Zhou H; Nie C; Tian W; Han X; Wang J; Du X; Wang Q; Zhu X; Xiang G; Zhao Y
Dig Dis Sci; 2023 Jul; 68(7):3009-3017. PubMed ID: 36961670
[TBL] [Abstract][Full Text] [Related]
69. Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer.
Baumgart S; Glesel E; Singh G; Chen NM; Reutlinger K; Zhang J; Billadeau DD; Fernandez-Zapico ME; Gress TM; Singh SK; Ellenrieder V
Gastroenterology; 2012 Feb; 142(2):388-98.e1-7. PubMed ID: 22079596
[TBL] [Abstract][Full Text] [Related]
70. Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1.
Basu S; Liu Q; Qiu Y; Dong F
Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1433-8. PubMed ID: 19164764
[TBL] [Abstract][Full Text] [Related]
71. Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals.
Wu X; Bekker-Jensen IH; Christensen J; Rasmussen KD; Sidoli S; Qi Y; Kong Y; Wang X; Cui Y; Xiao Z; Xu G; Williams K; Rappsilber J; Sønderby CK; Winther O; Jensen ON; Helin K
Cell Res; 2015 Nov; 25(11):1205-18. PubMed ID: 26470845
[TBL] [Abstract][Full Text] [Related]
72. Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex.
Thillainadesan G; Isovic M; Loney E; Andrews J; Tini M; Torchia J
Mol Cell Biol; 2008 Oct; 28(19):6066-77. PubMed ID: 18625718
[TBL] [Abstract][Full Text] [Related]
73. Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma.
Walker BA; Wardell CP; Chiecchio L; Smith EM; Boyd KD; Neri A; Davies FE; Ross FM; Morgan GJ
Blood; 2011 Jan; 117(2):553-62. PubMed ID: 20944071
[TBL] [Abstract][Full Text] [Related]
74. Epigenetic events underlie the pathogenesis of sinonasal papillomas.
Stephen JK; Vaught LE; Chen KM; Sethi S; Shah V; Benninger MS; Gardner GM; Schweitzer VG; Khan M; Worsham MJ
Mod Pathol; 2007 Oct; 20(10):1019-27. PubMed ID: 17673925
[TBL] [Abstract][Full Text] [Related]
75. p15(INK4b) regulates cell cycle signaling in hippocampal astrocytes of aged rats.
Wang F; Zhang L
Aging Clin Exp Res; 2016 Oct; 28(5):813-21. PubMed ID: 26526028
[TBL] [Abstract][Full Text] [Related]
76. Frequent CDKN2B/P15 and DAPK1 methylation in duodenal follicular lymphoma is related to duodenal reactive lymphoid hyperplasia.
Takata K; Miyata-Takata T; Sato Y
J Clin Exp Hematop; 2024; 64(2):129-137. PubMed ID: 38925973
[TBL] [Abstract][Full Text] [Related]
77. Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia.
Chim CS; Kwong YL
Leuk Lymphoma; 2006 May; 47(5):815-25. PubMed ID: 16753865
[TBL] [Abstract][Full Text] [Related]
78. p15Ink4b: dual function in myelopoiesis and inactivation in myeloid disease.
Rosu-Myles M; Wolff L
Blood Cells Mol Dis; 2008; 40(3):406-9. PubMed ID: 18029205
[TBL] [Abstract][Full Text] [Related]
79. DNA methylation analysis of the gene CDKN2B in Gallus gallus (chicken).
Gryzińska M; Andraszek K; Jocek G
Folia Biol (Krakow); 2013; 61(3-4):165-71. PubMed ID: 24279164
[TBL] [Abstract][Full Text] [Related]
80. SAMSN1 is a tumor suppressor gene in multiple myeloma.
Noll JE; Hewett DR; Williams SA; Vandyke K; Kok C; To LB; Zannettino AC
Neoplasia; 2014 Jul; 16(7):572-85. PubMed ID: 25117979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
